Results 221 to 230 of about 5,053,091 (357)
Proton therapy of cancer: Potential clinical advantages and cost-effectiveness [PDF]
Jonas Lundkvist+4 more
openalex +1 more source
These findings suggest that UCP2 promotes LD formation and release in acinar cells by upregulating ACSL3 expression. This alteration in the local lipid metabolic environment indirectly drives the MMT process. Additionally, UCP2 may regulate the acetylation of Smad3 through Sirt1, enhancing its nuclear activity and activating the TGF‐β/ Smad3 signaling ...
Kunpeng Wang+9 more
wiley +1 more source
Systematic review and meta‐analysis: enhanced efficacy of proton‐pump inhibitor therapy for peptic ulcer bleeding in Asia – a
Grigoris I. Leontiadis+2 more
openalex +1 more source
Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
A. Moreno+11 more
semanticscholar +1 more source
CTSK plays a critical role in pulmonary fibrosis. Excessive CTSK accumulation interacts with SNX9 to enhance TGF‐β1‐induced SMAD3 activation and GLS1 expression in fibroblasts, driving glutamine metabolism for collagen biosynthesis and exacerbating pulmonary fibrosis.
Mengting Chen+10 more
wiley +1 more source
The research beamlines at the Dresden proton therapy facility: available infrastructure and experimental capabilities. [PDF]
Horst F+12 more
europepmc +1 more source
Donut-Shaped High-Dose Configuration for Proton Beam Radiation Therapy [PDF]
Hans Rutz, Antony Lomax
openalex +1 more source
Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology
This study investigates the impact of Aβ plaques on α‐synuclein (αSyn) pathologies in dementia with Lewy bodies (DLB). Co‐culturing primary neurons with AD mouse brain slices reveals impaired dynein‐dependent organelle trafficking, affecting αSyn degradation. Activating Rab7 restores this process, reducing αSyn inclusions.
Linlin Zhou+14 more
wiley +1 more source